Observational Study Evaluating the Efficacy and Tolerability of Anticancer Drug Therapies Adopted for the Treatment of Gynecologic and Breast Cancers in Clinical Practice Compared with the Results of Registration Studies
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY
retrospective/prospective observational study. Objective of the study is to evaluate the effect of drugs in terms of objective responses, disease-free survival (DFS), progression-free survival (PFS), overall survival (OS), and side effects compared with registry studies in the medical therapy of breast and gynecologic cancers.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Diagnosis of histologically confirmed breast cancer or gynecological cancer, either early stage or metastatic;
• Patients who have received treatment for breast cancer or gynecologic cancer since January 2010;
• Any patient currently living and actually contactable must sign an informed consent to the study and processing of personal data.
Locations
Other Locations
Italy
IRCCS Azienda Ospedaliero-Universitaria di Bologna
RECRUITING
Bologna
Contact Information
Primary
Claudio Zamagni, MD
zamagniclaudio.sper@aosp.bo.it
0512144548
Backup
Cinzia Pizzirani, PhD
cinzia.pizzirani@aosp.bo.it
0512144447
Time Frame
Start Date: 2024-03-22
Estimated Completion Date: 2030-12-31
Participants
Target number of participants: 100
Treatments
retrospective cohort
In this cohort data will be recorded retrospectively
prospective cohort
In this cohort data will be recorded prospectively
Related Therapeutic Areas
Sponsors
Leads: IRCCS Azienda Ospedaliero-Universitaria di Bologna